Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by Sonny7on Jan 25, 2018 6:45pm
185 Views
Post# 27436494

RE:And the truth is....

RE:And the truth is....It’s been said that the application rejection was an error on the part of the FDA from a lesser employee there who misinterpreted the end points and released news on his own accord to announce the rejection of the application. GA immediately started hollering about an appeal and then conversed with the proper dignitaries who admitted the error. FDA is not in th business to be attending appeals and proven wrong. In a face saving gesture, they changed some wording, waited thirty days and issued clearance for VMS. It did do damage to the share price with the rejection and the stock lost momentum. 
I dislike the FDA 
In any case that was back in the Bodtke era when the earth was still considered flat. To speak of that FDA episode is going backwards and VPT is a fresh and disruptive technology story now and on th brink of doing the World and us some good. I like to forget old news. Look forward
Bullboard Posts